Editorial overview: Use of PK-PD for antibacterial drug development: decreasing risk and paths forward for resistant pathogens

被引：5
作者：
Bhavnani, Sujata M. [1 ]
Rex, John H. [2 ]
机构：
[1] Inst Clin Pharmacodynam Inc, Translat Med, Schenectady, NY 12305 USA
[2] F2G Ltd, Manchester, Lancs, England
来源：
CURRENT OPINION IN PHARMACOLOGY | 2017年 / 36卷
关键词：
INHIBITORY CONCENTRATION; AMINOGLYCOSIDE THERAPY; NOSOCOMIAL PNEUMONIA; PHARMACODYNAMICS; PHARMACOKINETICS; BACTERIA; RATIO; MICE;
D O I：
10.1016/j.coph.2017.11.008
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：VIII / XII
页数：5
相关论文
共 35 条
[1]   Pharmacokinetics-pharmacodynamics of antimicrobial therapy: It's not just for mice anymore [J].
Ambrose, Paul G. ;
Bhavnani, Sujata M. ;
Rubino, Christopher M. ;
Louie, Arnold ;
Gumbo, Tawanda ;
Forrest, Alan ;
Drusano, George L. .
CLINICAL INFECTIOUS DISEASES, 2007, 44 (01) :79-86
[2]   Antibacterial drug development program successes and failures: a pharmacometric explanation [J].
Ambrose, Paul G. .
CURRENT OPINION IN PHARMACOLOGY, 2017, 36 :1-7
[3]  
Ambrose PG, 2017, CURR OPIN PHARM
[4]  
Andes DR, 2017, CURR OPIN PHARM
[5]  
[Anonymous], 2015, US PHARM PHARM DEV A
[6]  
[Anonymous], 2014, GUID IND HOSP ACQ BA
[7]  
[Anonymous], GUID IND COMM ACQ BA
[8]  
[Anonymous], FAC ANT DRUG DEV PAT
[9]  
Bhavnani SM, 2017, CURR OPIN PHARM
[10]   White Paper: Developing Antimicrobial Drugs for Resistant Pathogens, Narrow-Spectrum Indications, and Unmet Needs [J].
Boucher, Helen W. ;
Ambrose, Paul G. ;
Chambers, H. F. ;
Ebright, Richard H. ;
Jezek, Amanda ;
Murray, Barbara E. ;
Newland, Jason G. ;
Ostrowsky, Belinda ;
Rex, John H. .
JOURNAL OF INFECTIOUS DISEASES, 2017, 216 (02) :228-236
1234